In the present work, we showed that DMT1 silencing disrupts iron homeostasis in triple-negative breast cancer cells by decreasing EE-mitochondria interactions, reducing mitochondrial iron translocation, increasing LIP levels, and establishing a compensatory iron phenotype of elevated export/reduced import. The gene discussed is SLC11A2; the disease is triple-negative breast carcinoma.